These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35936347)

  • 1. CEO turnover and corporate innovation: What can we learn from Chinese listed companies.
    Sun S; Jiang H
    Front Psychol; 2022; 13():874907. PubMed ID: 35936347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive pharmaceutical background, R&D investment and corporate innovation performance.
    Zhang L; Li S; Wu M
    Am J Transl Res; 2023; 15(11):6576-6586. PubMed ID: 38074834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does CEO narcissism affect enterprise ambidextrous technological innovation? The mediating role of corporate social responsibility.
    Wang Z; Hu X; Yu F
    PLoS One; 2023; 18(1):e0280758. PubMed ID: 36662757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does China's centralized volume-based drug procurement policy facilitate the transition from imitation to innovation for listed pharmaceutical companies? Empirical tests based on double difference model.
    Gu Y; Zhuang Q
    Front Pharmacol; 2023; 14():1192423. PubMed ID: 37324496
    [No Abstract]   [Full Text] [Related]  

  • 5. Does chief executive officer turnover affect green innovation quality and quantity? Evidence from China's manufacturing enterprises.
    Zhang Y; Liu H; Li M
    Environ Sci Pollut Res Int; 2023 Jul; 30(34):81760-81782. PubMed ID: 35499719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of CEO Narcissism and Corporate R&D Investment.
    Wang L; Li H; Mu Y
    Front Psychol; 2022; 13():888618. PubMed ID: 35645881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating the effectiveness of cognitive CEO on corporate environmental performance: the mediating role of corporate innovation.
    Sarfraz M; He B; Shah SGM
    Environ Sci Pollut Res Int; 2020 Dec; 27(36):45938-45948. PubMed ID: 32808125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEO Overconfidence, Corporate Governance, and R&D Smoothing in Technology-Based Entrepreneurial Firms.
    Huang Y; Wang X; Li Y; Yu X
    Front Psychol; 2022; 13():944117. PubMed ID: 35910989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial performance of China's listed firms in presence of coronavirus: Evidence from corporate culture and corporate social responsibility.
    Zheng F; Zhao Z; Sun Y; Khan YA
    Curr Psychol; 2023; 42(11):8897-8918. PubMed ID: 34400856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From ratings to action: The impact of ESG performance on corporate innovation.
    Wang Y; Wang X
    Heliyon; 2024 Feb; 10(4):e26683. PubMed ID: 38420449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corporate financialization, financing constraints, and innovation efficiency-Empirical evidence based on listed Chinese pharmaceutical companies.
    Zhu J; Tang Y; Wei Y; Wang S; Chen Y
    Front Public Health; 2023; 11():1085148. PubMed ID: 37124778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEO successor origins, top management team faultline, and strategic change-empirical evidence from China.
    Ren D; Jiang H; Cheng J; Peng C; Zou Y
    Heliyon; 2023 Sep; 9(9):e19200. PubMed ID: 37662732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How High-Polluting Firms Suffer from Being Distracted form Intended Purpose: A Corporate Social Responsibility Perspective.
    Zhao XZ; Chen J; Chen FW; Wang W; Xia S
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33317027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Institutional pressures as drivers of corporate green innovation: do provincial officials and CEOs matter?
    Ren S; Wang M
    Environ Sci Pollut Res Int; 2023 Mar; 30(14):40608-40629. PubMed ID: 36622586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Chief Executives Matter in Corporate Financial and Social Responsibility Performance Nexus? A dynamic Model Analysis of Chinese Firms.
    Zahid RMA; Khurshid M; Khan W
    Front Psychol; 2022; 13():897444. PubMed ID: 35712198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEO Overconfidence and Corporate Innovation Outcomes: Evidence From China.
    Li Z; Zhang Y
    Front Psychol; 2022; 13():760102. PubMed ID: 35197895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial constraints, government subsidies, and corporate innovation.
    Li Q; Wang J; Cao G; Zhang J
    PLoS One; 2021; 16(11):e0259642. PubMed ID: 34758030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond transparency: Unpacking the financial effects of third-party environmental disclosure in China's semiconductor sector.
    Dagestani AA; Alnafrah I; Ding CJ; Qing L
    J Environ Manage; 2024 Jun; 360():121237. PubMed ID: 38796871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEO discretion and enterprise digital transformation.
    Wang Y; He Z
    Heliyon; 2024 Jan; 10(1):e23468. PubMed ID: 38173513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEO financial background, managerial ownership, and corporate innovation: Insights from imprinting theory.
    Gao Y; Tang Y; Zhang J
    Front Psychol; 2023; 14():1126853. PubMed ID: 36865362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.